Sitero

Sitero is a technology-enabled clinical trial services company founded in 2022, positioned at the intersection of digital health and clinical research operations. It provides an integrated offering of traditional CRO services (clinical operations, pharmacovigilance, biosafety) with a proprietary software suite, 'Mentor,' designed to streamline eConsent, EDC, payments, and compliance management. The company has grown through strategic acquisitions, such as Clario's eClinical technology suite, and partnerships, aiming to reduce administrative burden and accelerate study timelines for sponsors and sites. Sitero operates as a private, revenue-generating services business, not a drug developer, focusing on the infrastructure that supports clinical research.

The 'Mentor' suite, an integrated eClinical and eCompliance software platform encompassing modules for eConsent, EDC/ePRO, RTSM, CTMS/eTMF, site/participant payments, IRB, IBC, and IACUC management. Enhanced by SiteroAI for intelligent automation.

Sitero competes in the fragmented CRO and clinical trial technology markets. It faces large, full-service CROs (e.g., IQVIA, Parexel, PPD), specialized pharmacovigilance and biosafety providers, and a plethora of best-in-breed eClinical software vendors. Its differentiation lies in combining a broad service portfolio with a unified, proprietary technology platform.